Liheng Zhou

1.6k total citations
71 papers, 1.2k citations indexed

About

Liheng Zhou is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Liheng Zhou has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cancer Research, 33 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Liheng Zhou's work include Breast Cancer Treatment Studies (19 papers), Cancer-related molecular mechanisms research (16 papers) and HER2/EGFR in Cancer Research (12 papers). Liheng Zhou is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Cancer-related molecular mechanisms research (16 papers) and HER2/EGFR in Cancer Research (12 papers). Liheng Zhou collaborates with scholars based in China, United States and India. Liheng Zhou's co-authors include Jinsong Lu, Wenjin Yin, Yanping Lin, Tingting Yan, Yiwei Jiang, Shuguang Xu, Yueyao Du, Zhenzhou Shen, Ziping Wu and Gen‐Hong Di and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Liheng Zhou

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liheng Zhou China 20 598 571 410 231 79 71 1.2k
Renquan Lu China 21 343 0.6× 625 1.1× 405 1.0× 196 0.8× 45 0.6× 62 1.2k
Anli Yang China 24 780 1.3× 917 1.6× 381 0.9× 325 1.4× 96 1.2× 71 1.6k
Wenjun Yi China 20 402 0.7× 556 1.0× 268 0.7× 149 0.6× 65 0.8× 94 1.1k
Yuanjie Niu China 24 585 1.0× 982 1.7× 250 0.6× 404 1.7× 39 0.5× 45 1.5k
Ji‐Yeon Kim South Korea 23 414 0.7× 414 0.7× 523 1.3× 287 1.2× 184 2.3× 113 1.4k
Yuan Cheng China 18 291 0.5× 513 0.9× 298 0.7× 147 0.6× 136 1.7× 100 1.3k
Zhiqun Shang China 23 341 0.6× 690 1.2× 307 0.7× 485 2.1× 48 0.6× 70 1.2k
Lijun Xue China 23 260 0.4× 691 1.2× 413 1.0× 176 0.8× 68 0.9× 51 1.3k
Qin Yang China 20 415 0.7× 760 1.3× 182 0.4× 126 0.5× 51 0.6× 61 1.5k

Countries citing papers authored by Liheng Zhou

Since Specialization
Citations

This map shows the geographic impact of Liheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liheng Zhou more than expected).

Fields of papers citing papers by Liheng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liheng Zhou. The network helps show where Liheng Zhou may publish in the future.

Co-authorship network of co-authors of Liheng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Liheng Zhou. A scholar is included among the top collaborators of Liheng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liheng Zhou. Liheng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Yumei, et al.. (2025). Metronomic chemotherapy of paclitaxel plus cisplatin in patients with metastatic breast cancer: a target trial emulation study. Therapeutic Advances in Medical Oncology. 17. 22828964–22828964.
4.
Zhou, Liheng, et al.. (2024). Allopurinol Disrupts Purine Metabolism to Increase Damage in Experimental Colitis. Cells. 13(5). 373–373. 9 indexed citations
5.
Yuan, Chenwei, Yaqian Xu, Liheng Zhou, et al.. (2024). Value of CDR1-AS as a predictive and prognostic biomarker for patients with breast cancer receiving neoadjuvant chemotherapy in a prospective Chinese cohort. European journal of medical research. 29(1). 454–454. 1 indexed citations
8.
Wan, Caifeng, Liheng Zhou, Ye Jin, et al.. (2023). Strain ultrasonic elastography imaging features of locally advanced breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival. BMC Medical Imaging. 23(1). 216–216. 3 indexed citations
9.
Zhang, Wenli, et al.. (2023). Textural effect of Pt catalyst layers with different carbon supports on internal oxygen diffusion during oxygen reduction reaction. Frontiers in Chemistry. 11. 1217565–1217565. 3 indexed citations
10.
Wan, Caifeng, Liheng Zhou, Hongli Li, et al.. (2023). Multiparametric Contrast-Enhanced Ultrasound in Early Prediction of Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival in Breast Cancer. Diagnostics. 13(14). 2378–2378. 6 indexed citations
11.
Wu, Yifan, Yaohui Wang, Yaohui Wang, et al.. (2023). Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism. Analytica Chimica Acta. 1283. 341897–341897. 8 indexed citations
12.
Yin, Wenjin, Yaohui Wang, Ziping Wu, et al.. (2022). Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study. Clinical Cancer Research. 28(17). 3677–3685. 26 indexed citations
13.
Wu, Ziping, Jing Peng, Shuguang Xu, et al.. (2020). Programmed death-ligand 1 single nucleotide polymorphism affects breast cancer chemosensitivity and adverse events in the neoadjuvant setting. The International Journal of Biological Markers. 35(3). 38–49. 2 indexed citations
15.
Wu, Ziping, Lei Zhang, Jing Peng, et al.. (2019). Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting. Cancer Biology & Therapy. 20(6). 941–947. 16 indexed citations
16.
Sheng, Xiaonan, Yaohui Wang, Fan Yang, et al.. (2019). Ultrasound-Guided Breast Biopsy: Improved Accuracy of 10-G Cable-Free Elite Compared With 14-G CCNB. Journal of Surgical Research. 247. 172–179. 6 indexed citations
17.
Yin, Kai, Wenjin Yin, Yaohui Wang, et al.. (2016). MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells. Oncotarget. 7(17). 24537–24548. 64 indexed citations
18.
Jiang, Yiwei, Wenjin Yin, Liheng Zhou, et al.. (2012). First Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis. PLoS ONE. 7(3). e32474–e32474. 16 indexed citations
19.
Jiang, Yiwei, Liheng Zhou, Tingting Yan, et al.. (2010). Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue. Journal of Experimental & Clinical Cancer Research. 29(1). 101–101. 16 indexed citations
20.
Lin, Yanping, Wenjin Yin, Tingting Yan, et al.. (2009). Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. BMC Cancer. 9(1). 342–342. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026